Cargando…
Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity
The association of Zika virus (ZIKV) infection and severe complications including neurological sequelae especially fetal microcephaly has aroused global attentions since its outbreak in 2015. Currently, there are no vaccines or therapeutic drugs clinically approved for treatments of ZIKV infection,...
Autores principales: | Chen, Yongkang, Li, Yuan, Wang, Xiaohuan, Zou, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002393/ https://www.ncbi.nlm.nih.gov/pubmed/32082265 http://dx.doi.org/10.3389/fmicb.2019.03079 |
Ejemplares similares
-
Montelukast Inhibits HCoV-OC43 Infection as a Viral Inactivator
por: Chen, Yongkang, et al.
Publicado: (2022) -
Erythromycin Estolate Inhibits Zika Virus Infection by Blocking Viral Entry as a Viral Inactivator
por: Wang, Xiaohuan, et al.
Publicado: (2019) -
The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain
por: Eriksson, Yohanna, et al.
Publicado: (2018) -
196 Effect of the Treatment With Montelukast in Asthmatic Patient
por: Aguila de la Coba, Roberto O., et al.
Publicado: (2012) -
Montelukast Use Decreases Cardiovascular Events in Asthmatics
por: Hoxha, Malvina, et al.
Publicado: (2021)